This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Huons Co., Ltd., Samsung Electronics Co., Ltd.. Active years: 1996-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2020
Title: Yeong-Mok Kim: Innovator in Peptide Technology
Introduction
Yeong-Mok Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of peptide technology, particularly in the development of compositions that utilize RGD motif-containing peptides. With a total of 4 patents to his name, his work has the potential to impact various medical and cosmetic applications.
Latest Patents
One of Yeong-Mok Kim's latest patents involves a composition containing an RGD motif-containing peptide or a fragment thereof. This invention is designed for treating burns and glaucoma, alleviating skin wrinkles, and promoting hair growth. The peptide effectively addresses these conditions and can be utilized in both cosmetic and pharmaceutical compositions. The innovative approach of using RGD motif-containing peptides highlights the versatility and potential of his research.
Career Highlights
Throughout his career, Yeong-Mok Kim has worked with notable companies such as Huons Co., Ltd. and Samsung Electronics Co., Ltd. His experience in these organizations has allowed him to refine his expertise in peptide technology and contribute to advancements in the field.
Collaborations
Some of his notable coworkers include Key-An Um and Jong Hwan Lim. Their collaborative efforts have likely played a role in the development of innovative solutions in peptide research.
Conclusion
Yeong-Mok Kim's contributions to peptide technology demonstrate his commitment to innovation and improvement in medical and cosmetic fields. His patents reflect a deep understanding of the potential applications of RGD motif-containing peptides, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
